Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial
- PMID: 20144926
- PMCID: PMC2909791
- DOI: 10.1093/rheumatology/kep464
Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial
Abstract
Objectives: To characterize the baseline tendon friction rubs (TFRs) in early dcSSc and to evaluate the association of change in TFR over 6 and 12 months with changes in modified Rodnan skin score (MRSS) and HAQ-Disability Index (HAQ-DI) over 12 and 24 months, respectively.
Methods: We analysed data from the d-Pen study, a 2-year study in early dcSSc (< or =18 months from first non-Raynaud's symptom). TFR was scored as present/absent at seven anatomical sites at baseline and every 6 months thereafter. Multivariable linear regression models assessed associations between TFR and change in MRSS, and change in the HAQ-DI, over 12 and 24 months, respectively. Covariates included baseline TFR, change in the TFR over 6 and 12 months, age, sex, duration of SSc, MRSS, and tender joint count and swollen joint count (SJC).
Results: Forty-nine (37%) of 134 patients had TFR at baseline, 50% had resolution of their TFR, whereas 21% developed new TFRs. Patients with baseline TFRs were likely to be Caucasian (86 vs 58%) and had a higher HAQ-DI score (P = 0.008). In regression analyses, change in TFR (P = 0.04) and baseline MRSS (P = 0.03) predicted change in MRSS over a 12-month period (Model R(2 )= 0.14). For the HAQ-DI model, independent predictors were change in TFR at 6 months (P = 0.008) and baseline SJC (P = 0.04, Model R(2 )= 0.19). Results were similar for 24-month models.
Conclusions: We document the presence of TFR very early in the course of dcSSc. Changes in TFR over 6 and 12 months predict changes in MRSS and HAQ-DI over 12 and 24 months, respectively.
Figures
Similar articles
-
A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials.Rheumatology (Oxford). 2023 Apr 3;62(4):1543-1551. doi: 10.1093/rheumatology/keac501. Rheumatology (Oxford). 2023. PMID: 36031807 Free PMC article.
-
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database.Arthritis Res Ther. 2020 Oct 28;22(1):257. doi: 10.1186/s13075-020-02329-2. Arthritis Res Ther. 2020. PMID: 33115544 Free PMC article.
-
Changes in disability and their relationship with skin thickening, in diffuse and limited cutaneous systemic sclerosis: a retrospective cohort study.Scand J Rheumatol. 2019 May;48(3):230-234. doi: 10.1080/03009742.2018.1523455. Epub 2018 Nov 5. Scand J Rheumatol. 2019. PMID: 30394164
-
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis.Ann Rheum Dis. 2016 Oct;75(10):1743-8. doi: 10.1136/annrheumdis-2015-208024. Epub 2016 Mar 25. Ann Rheum Dis. 2016. PMID: 27016052 Free PMC article.
-
Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis.Arthritis Care Res (Hoboken). 2013 Aug;65(8):1385-9. doi: 10.1002/acr.21964. Arthritis Care Res (Hoboken). 2013. PMID: 23371412 Free PMC article.
Cited by
-
Sclerodermic hand: a retrospective study on the role of ultrasonography in the detection of subclinical joint involvement.Clin Rheumatol. 2023 Oct;42(10):2873-2879. doi: 10.1007/s10067-023-06668-8. Epub 2023 Jun 21. Clin Rheumatol. 2023. PMID: 37341932
-
Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.Rheumatol Int. 2019 Nov;39(11):1841-1848. doi: 10.1007/s00296-019-04402-9. Epub 2019 Aug 2. Rheumatol Int. 2019. PMID: 31375891
-
Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives.Expert Opin Orphan Drugs. 2016;4(1):31-47. doi: 10.1517/21678707.2016.1114454. Epub 2015 Nov 23. Expert Opin Orphan Drugs. 2016. PMID: 27812432 Free PMC article.
-
Assessment of skin involvement in systemic sclerosis.Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v53-v66. doi: 10.1093/rheumatology/kex202. Rheumatology (Oxford). 2017. PMID: 28992173 Free PMC article.
-
Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry.Chest. 2014 Dec;146(6):1494-1504. doi: 10.1378/chest.13-3014. Chest. 2014. PMID: 24992469 Free PMC article.
References
-
- Medsger TA., Jr Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am. 2003;29:255–73, vi. - PubMed
-
- Steen VD, Medsger TA., Jr The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis. Arthritis Rheum. 1997;40:1146–51. - PubMed
-
- Westphal C. Zwei Falle Von Schlerodermie. Chariete Annalen. 1876;3:341–60.
-
- Shulman LE, Kurban AK, Harvey AM. Tendon friction rubs in progressive system sclerosis (scleroderma) Trans Assoc Am Physician. 1961;74:378–88. - PubMed
-
- Rodnan GP, Medsger TA. The rheumatic manifestaions of progressive systemic sclerosis (scleroderma) Clin Orthop Relat Res. 1968;57:81–93. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical